Peptides of the liver stage antigen-1 (LSA-1) of Plasmodium falciparum bind to human hepatocytes

Peptides

Volumn 24, Issue 5, 2003, Pages 647-657

  García, Javier E ^a   Puentes, Alvaro ^a   López, Ramsés ^a   Vera, Ricardo ^a   Suárez, Jorge ^a   Rodríguez, Luis ^a   Curtidor, Hernando ^a   Ocampo, Marisol ^a   Tovar, Diana ^a   Forero, Martha ^a   Bermudez, Adriana ^a   Cortés, Jimena ^a   Urquiza, Mauricio ^a   Patarroyo, Manuel E ^a  

^a UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

Author keywords

Critical residues; High activity binding peptides (HABPs); Liver stage antigen (LSA); P. falciparum; Phosphate buffered saline (PBS); Red blood cells (RBC)

Indexed keywords

ASPARTYLLYSYLGLUTAMYLLEUCYLTHREONYLMETHIONYLSERYLASPARAGINYLVALYLLYSYLASPAR AGINYLVALYLSERYLGLUTAMINYLTHREONYLASPARAGINYLPHENYLALANYLLYSYLSERYLLEUCYLTYROSIN E; CYSTEINYLGLYCYLISOLEUCYLASPARAGINYLGLYCYLLYSYLASPARAGINYLISOLEUCYLLYSYLASPA RAGINYLALANYLGLUTAMYLLYSYLPROLYLMETHIONYLISOLEUCYLISOLEUCYLLYSYLSERYLASPARAGINYL LEUCYLARGINYLGLYCYLCYSTEINE; ISOLEUCYLASPARAGINYLGLYCYLLYSYLISOLEUCYLISOLEUCYLLYSYLASPARAGINYLSERYLGLUTA MYLLYSYLASPARTYLGLUTAMYLISOLEUCYLISOLEUCYLLYSYLSERYLASPARAGINYLLEUCYLARGINYLTYRO SINE; LIVER STAGE ANTIGEN 1; LYSYLGLUTAMYLLYSYLLEUCYLGLUTAMINYLGLUTAMYLGLUTAMINYLGLUTAMINYLSERYLASPARTYL LEUCYLGLUTAMYLGLUTAMINYLGLUTAMYLARGINYLARGINYLALANYLTYROSINE; LYSYLGLUTAMYLLYSYLLEUCYLGLUTAMINYLGLUTAMYLGLUTAMINYLGLUTAMINYLSERYLASPARTYL LEUCYLGLUTAMYLGLUTAMINYLGLUTAMYLARGINYLLEUCYLALANYLTYROSINE; LYSYLGLUTAMYLLYSYLLEUCYLGLUTAMINYLGLYCYLGLUTAMINYLGLUTAMINYLSERYLASPARTYLSE RYLGLUTAMYLGLUTAMINYLGLUTAMYLARGINYLARGINYLALANYLTYROSINE; PARASITE ANTIGEN; UNCLASSIFIED DRUG;

ANTIGEN BINDING; ARTICLE; CELL SURFACE; ERYTHROCYTE; HUMAN; HUMAN CELL; IMMUNOGENICITY; LIVER CELL; MALARIA FALCIPARUM; MEMBRANE BINDING; NONHUMAN; PARASITE; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTOZOAL INFECTION; STATISTICAL SIGNIFICANCE;

PLASMODIUM FALCIPARUM;

EID: 12444344702     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(03)00135-9     Document Type: Article

References (35)

1. Aden D., Fogel A., Plotkin S., Damjanov I., Knowles B. Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line. Nature. 282:1979;615-616.
2. Bchini R., Capel F., Dauguet C.H., Dubanchet S., Petit A.M. In vitro infection of human hepatoma (HepG2) cell with hepatitis B virus. J. Virol. 64:1990;3025-3032.
3. Escalante A.A., Lal A.A., Ayala F.J. Genetic polymorphism and natural selection in the malaria parasite Plasmodium falciparum. Genetics. 149:1998;189-202.
4. Espejo F., Cubillos M., Purmova J., Guzman F., Urquiza M., Ocampo M.et al. Structure, immunogenicity, and protective relationship for the 1585 malarial peptide and its substitution analogues. Angew. Chem. Int. Ed. 40:2001;4654-4657.
5. Ferreira-Da-Cruz M.F., Deslandes D.C., Oliveira-Ferreira J., Montenegro-James S., Tartar A., Druilhe P.et al. Antibody responses to Plasmodium falciparum sporozoite-, liver- and blood-stage syntthetic peptides in migrant and autochthonous populations in malaria endemic areas. Parasite. 2:1995;23-29.
6. Fidock D.A., Bottius E., Brahimi K., Moelans I.I., Aikawa M., Konings R.N.et al. Cloning and characterization of a novel Plasmodium falciparum sporozoite surface antigen, STARP. Mol. Biochem. Parasitol. 64:1994;219-232.
7. Fidock D.A., Gras-Masse H., Lepers J.P., Brahimi K., Benmohamed L., Mellouk S.et al. Plasmodium falciparum liver stage antigen-1 is well conserved and contains potent B and T-cell determinants. J. Immunol. 153:1994;190-204.
8. García J., Puentes A., Suarez J., Lopez R., Vera R., Rodriguez L.E.et al. Regions of HCV E1 and E2 proteins of hepatitis C virus that binding specifically to HepG2 cells. J. Hepatol. 36:2002;254-262.
9. Gueri-Marchand C., Druilhe P., Galey B., Londono A., Patarapotikul J., Beaudoin R.et al. A liver-specific antigen of Plasmodium falciparum characterised by gene cloning. Nature. 329:1987;164-167.
10. Hoffman SL, Franke ED, Hollingdale MR, Druilhe P. Attacking the infected hepatocyte. In: Hoffman S, editor. Malaria vaccine development: a multi-immune response approach. Washington, DC: ASM Press; 1996. p. 35-75.
11. Hollingdale M.R., Aikawa M., Atkinson C.T., Ballou R., Chen G., Li J.et al. Non-Cs pre-erythrocytic protective antigens. Immunol. Lett. 25:1990;71-76.
12. Hollingdale M.R., McCormick C.J., Heal K.G., Tailor-Robinson A.W., Reeve P., Boykins R.et al. Biology of malarial liver stages: implications for vaccine design. Ann. Trop Med. Parasitol. 92:1998;411-417.
13. Hubbard A.L., Wall D.A., Ma A. Isolation of rat hepatocyte plasma membranes. J. Cell Biol. 96:1983;217-229.
14. Hulme EC. Receptor-ligand interactions. A practical approach. New York: Oxford University Press; 1993.
15. John C.C., Sumba P.O., Ouma J.H., Nahlen B.L., King C.L., Kazura J.W. Cytokine responses to Plasmodium falciparum liver-stage antigen 1 vary in rainy and dry seasons in highland Kenya. Infect. Immun. 68:2000;5198-5204.
16. Joshi M.B., Gam A.A., Boykins R.A., Kumar S., Sacci J., Hoffman S.L.et al. Immunogenicity of well-characterized synthetic Plasmodium falciparum multiple antigen peptide conjugates. Infect. Immun. 69:2001;4884-4890.
17. Krzych U., Lyon J.A., Jareed T., Schneider I., Hollingdale M.R., Gordon D.M.et al. T lymphocytes from volunteers immunized with irradiated Plasmodium falciparum sporozoites recognize liver and blood stage malaria antigens. J. Immunol. 155:1995;4072-4077.
18. Kurtis J.D., Hollingdale M.R., Luty A.J., Lanar D.E., Krzych U., Duffy P.E. Pre-erythrocytic immunity to Plasmodium falciparum: the case for an LSA-1 vaccine. Trends Parasitol. 17:2001;219-223.
19. Kurtis J.D., Lanar D.E., Opollo M., Duffy P.E. Interleukin-10 responses to liver-stage antigen 1 predict human resistance to Plasmodium falciparum. Infect. Immun. 67:1999;3424-3429.
20. Lopez R., Curtidor H., Urquiza M., García J., Puentes A., Suarez J.et al. Plasmodium falciparum: binding studies of peptide derived from the sporozoite surface protein 2 to HepG2 cells. J. Peptide Res. 58:2001;1-11.
21. Luty A.J., Lell B., Schmidt-Ott R., Lehman L.G., Luckner D., Greve B.et al. Parasite antigen-specific interleukin-10 and antibody reponses predict accelerated parasite clearance in Plasmodium falciparum malaria. Eur. Cytokine Netw. 9:1998;639-646.
22. Merrifield R.B. Solid phase peptide synthesis. I. The synthesis of a tetrapeptide. J. Am. Chem. Soc. 85:1963;2149-2154.
23. Nardin E.H., Nussenzweig R.S. T cell responses to pre-erythrocytic stages of malaria: role in protection and vaccine development against pre-erythrocytic stages. Annu. Rev. Immunol. 11:1993;687-727.
24. Neurath A.R., Kent S.B.H., Strick N., Parker K. Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virus. Cell. 46:1986;429-436.
25. Puentes A., García J., Vera R., Lopez R., Urquiza M., Vanegas M. Serine repeat antigen peptides bind specifically to red blood cells. Parasitol. Int. 49:2000;105-117.
26. Purmova J., Salazar L.M., Espejo F., Torres M.H., Cubillos M., Torres E.et al. NMR structure of Plasmodium falciparum malaria peptide correlates with protective immunity. Biochim. Biophys. Acta. 96:2002;217-229.
27. Rodriguez L.E., Urquiza M., Ocampo M., Suarez J., Curtidor H., Guzman F. Plasmodium falciparum EBA-175 kDa protein peptide which binds to human red blood cells. Parasitology. 120:2000;225-235.
28. Sinnis P, Nussenzweig V. Preventing sporozoite invasion of hepatocytes. In: Hoffman S, editor. Malaria vaccine development: a multi-immune response approach. Washington, DC: ASM Press; 1996. p. 15-33.
29. Súarez J.E., Urquiza M., Puentes A., García J.E., Ocampo M., López R.et al. Plasmodium falciparum: circumsporozoite (CS) protein peptides specifically bind to HepG2. Vaccine. 19:2001;4487-4495.
30. Tine J.A., Lanar D.E., Smith D.M., Wellde B.T., Schultheiss P., Ware L.A.et al. NYVAC-Pf7: a poxvirus-vectored multi-antigen multistage vaccine candidate for Plasmodium falciparum malaria. Infect. Immun. 64:1996;3833-3844.
31. Urquiza M., Rodriguez L., Suarez J., Guzman F., Ocampo M., Curtidor H.et al. Identification of peptides from the Plasmodium falciparum MSP-1 protein able to bind to red blood cells. Parasite Immunol. 18:1996;515-526.
32. Weiland G.A., Molinoff P.B. Quantitative analysis of drug-receptor interactions. 1. Determinations of kinect and equilibrium properties. Life Sci. 29:1981;311-313.
33. Yamamura HY, Enna SJ, Kuhar M. Neurotransmitter receptor binding. New York: Raven Press; 1978.
34. Yang C.H., Shi Y.P., Udhayakumar V., Alpers M.P., Povoa M.M., Hawley W.A.et al. Sequence variations in the non-repetitive regions of the liver stage-specific antigen-1 (LSA-1) of Plasmodium falciparum from field isolates. Mol. Biochem. Parasitol. 71:1995;291-294.
35. Zhu J., Hollingdale M.R. Structure of Plasmodium falciparum liver stage antigen 1. Mol. Biochem. Parasitol. 48:1991;223-226.